Back to Directory

Ziconotide

Performance & Endurance

Synthetic cone snail venom peptide for severe chronic pain, intrathecal administration only.

Key Benefits

  • ✓Severe pain relief
  • ✓Non-opioid mechanism
  • ✓No tolerance development
  • ✓Alternative to intrathecal morphine
  • ✓For refractory pain

Dosing Information

Dosage Range
0.1-19.2 mcg/day
Frequency
Continuous intrathecal
Typical Duration
Ongoing

Detailed Protocol

Administered via intrathecal pump directly into spinal fluid. Requires surgical pump implantation. Very slow dose titration over weeks. Specialized pain management only.

About Ziconotide

Ziconotide (Prialt) is a synthetic version of ω-conotoxin MVIIA from cone snail venom. It blocks N-type calcium channels, providing analgesia without opioid effects. FDA-approved for severe chronic pain when intrathecal route acceptable.

Research Notes

FDA-approved in 2004 for severe chronic pain. Derived from cone snail venom. Complex administration and significant CNS effects limit use to refractory cases. Specialized centers only.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Dizziness
  • •Confusion
  • •Memory impairment
  • •Ataxia
  • •Hallucinations (possible)
  • •Requires pump implantation
  • •Narrow therapeutic window

Always consult with a healthcare professional before starting any peptide therapy.